Annovis Bio Inc
(ANVS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -14,487 | -8,573 | -5,724 | -3,200 | -5,462 |
| Depreciation Amortization | N/A | N/A | N/A | N/A | 1 |
| Accounts receivable | N/A | N/A | N/A | N/A | 735 |
| Accounts payable and accrued liabilities | 346 | -52 | -232 | 483 | -696 |
| Other Working Capital | 657 | 392 | 73 | 701 | -401 |
| Other Operating Activity | 4,351 | 870 | 264 | -459 | 1,852 |
| Operating Cash Flow | $-9,132 | $-7,363 | $-5,619 | $-2,475 | $-3,971 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 46,744 | 46,648 | 46,674 | N/A | 12,044 |
| Other Financing Activity | 0 | 95 | 95 | 3 | 0 |
| Financing Cash Flow | $46,744 | $46,744 | $46,769 | $3 | $12,044 |
| Beginning Cash Position | 8,075 | 8,075 | 8,075 | 8,075 | 2 |
| End Cash Position | 45,686 | 47,455 | 49,224 | 5,603 | 8,075 |
| Net Cash Flow | $37,611 | $39,381 | $41,150 | $-2,472 | $8,073 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,132 | -7,363 | -5,619 | -2,475 | -3,971 |
| Free Cash Flow | -9,132 | -7,363 | -5,619 | -2,475 | -3,971 |